Flortaucipir (tau) PET in LGI1 antibody encephalitis

Flortaucipir (tau) PET in LGI1 antibody encephalitis

Abstract The contributors to persistent cognitive impairment and hippocampal atrophy in leucine‐rich glioma‐inactivated 1 antibody encephalitis (LGI1) patients are unknown. We evaluated whether tau neuropathology measured with [18F]flortaucipir PET neuroimaging associated with persistent cognitive i...

Full description

Bibliographic Details
Main Authors:	Gregory S. Day, Brian A. Gordon, Austin McCullough, Robert C. Bucelli, Richard J. Perrin, Tammie L. S. Benzinger, Beau M. Ances
Format:	Article
Language:	English
Published:	Wiley 2021-02-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51297

Similar Items

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
by: Richard M. Tsai, et al.
Published: (2019-01-01)

Evaluation of a visual interpretation method for tau‐PET with 18F‐flortaucipir
by: Ida Sonni, et al.
Published: (2020-01-01)

The Clinical Value of 18F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody
by: Xiao Liu, et al.
Published: (2020-06-01)

Clinical features of limbic encephalitis with LGI1 antibody
by: Wang ML, et al.
Published: (2017-06-01)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Yoonhyuk Jang, et al.
Published: (2018-09-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
by: Tessa Timmers, et al.
Published: (2019-07-01)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET
by: Shannon L. Risacher, et al.
Published: (2018-10-01)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
by: Jianping Qiao, et al.
Published: (2020-04-01)

Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
by: Michael J. Pontecorvo, et al.
Published: (2020-06-01)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
by: Dominique Endres, et al.
Published: (2020-06-01)

Pilomotor Seizures in a Patient With LGI1 Encephalitis
by: Jinxia Yang, et al.
Published: (2020-02-01)

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies
by: Tuo Ji, et al.
Published: (2020-09-01)

Cross‐sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
by: Brian A. Gordon, et al.
Published: (2018-01-01)

Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis
by: Hai-lun Hang, et al.
Published: (2020-08-01)

Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study
by: Weishuai Li, et al.
Published: (2018-07-01)

Selective Limbic Blood–Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies
by: Anna R. Tröscher, et al.
Published: (2017-10-01)

A case of anti-LGI-1 encephalitis presented as acute psychosis
by: Mohammed Reyazuddin, et al.
Published: (2020-06-01)

Impact of spill-in counts from off-target regions on [18F]Flortaucipir PET quantification
by: Aguiar, P., et al.
Published: (2022)

Isolated Chorea Associated with LGI1 Antibody
by: Ritesh A. Ramdhani, et al.
Published: (2014-01-01)

Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
by: Jingjing Feng, et al.
Published: (2021-10-01)

Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review
by: Xuanting Li, et al.
Published: (2019-02-01)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
by: Keith A. Josephs, et al.
Published: (2020-05-01)

Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET
by: Daria Pawlik, et al.
Published: (2020-11-01)

Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [18F]-APN-1607 Study
by: Huiwei Zhang, et al.
Published: (2021-06-01)

Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies
by: Ricardo Otiniano-Sifuentes, et al.
Published: (2021-01-01)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
by: Christian Thomas, et al.
Published: (2018-08-01)

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABABR encephalitis
by: Chun‐Hong Shen, et al.
Published: (2020-08-01)

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
by: Hee Jin Kim, et al.
Published: (2019-08-01)

Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis
by: Bhattacharyya, S., et al.
Published: (2022)

Morvan syndrome associated with LGI1 antibody: a case report
by: Shui-Jing Zhang, et al.
Published: (2021-05-01)

Imaging findings in faciobrachial dystonic seizures associated with LGI-1 antibodies
by: Ronnyson Susano Grativvol, et al.

Altered Mental Status in the Emergency Department – When to Consider Anti-LGI-1 Encephalitis: Case Report
by: Stephanie S. Miljkovic, et al.
Published: (2021-08-01)

Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report
by: Fujita, H., et al.
Published: (2022)

LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11
by: Koji Sagane, Yasushi Ishihama, Hachiro Sugimoto
Published: (2008-01-01)

HZ. PEYGAMBER'iN BiLGiSi VE BiLGi ALANLARI
by: Ahmet YILDIRIM
Published: (2003-12-01)

Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
by: Jennifer L. Whitwell, et al.
Published: (2020-01-01)

A case study of voltage-gated potassium channel antibody-related limbic encephalitis with PET/MRI findings
by: Brian K. Day, et al.
Published: (2015-01-01)

LGI Proteins in the Nervous System
by: Linde Kegel, et al.
Published: (2013-05-01)

PET Scan and Autoimmune Focal Encephalitis
by: J Gordon Millichap
Published: (2010-02-01)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
by: Christopher G. Schwarz, et al.
Published: (2021-09-01)